Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Toll-Like Receptors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT02650635
What this trial is testing

TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors

Who this might be right for
Colorectal AdenocarcinomaMetastatic Pancreatic AdenocarcinomaRecurrent Breast Carcinoma+14 more
Mayo Clinic 4
Not applicableStudy completedNCT00356746
What this trial is testing

Inflammatory Response During Anesthesia and Surgery

Who this might be right for
Systemic Inflammatory Response SyndromeMyocardial Ischemia
UMC Utrecht 120
Early research (Phase 1)Study completedNCT01590654
What this trial is testing

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Who this might be right for
Hepatitis B
Gilead Sciences 51
Not applicableLooking for participantsNCT00710112
What this trial is testing

Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants

Who this might be right for
Chronic Lung Disease
Medical College of Wisconsin 1,100
Not applicableUnknownNCT00893711
What this trial is testing

Lactobacillus Reuteri Versus Placebo in the Treatment and Prevention of Infantile Colic

Who this might be right for
Infantile Colic
Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna 155
Testing effectiveness (Phase 2)WithdrawnNCT02754362
What this trial is testing

A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma

Who this might be right for
GlioblastomaGlioma
NYU Langone Health
Not applicableStudy completedNCT01740817
What this trial is testing

Evaluate the Effect of Lipid Infusion on Toll Like Receptor 4 (TLR4) Signaling

Who this might be right for
DiabetesObesity
The University of Texas Health Science Center at San Antonio 12
Not applicableStudy completedNCT01439048
What this trial is testing

Placental and Cord Blood Markers Associated With Premature Birth and Disorders of Premature Birth in Newborn Infants

Who this might be right for
Premature Birth
Medical College of Wisconsin 82
Testing effectiveness (Phase 2)Study completedNCT01899729
What this trial is testing

A 12-week Dose-Ranging Trial in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Idera Pharmaceuticals, Inc. 46
Testing effectiveness (Phase 2)UnknownNCT04969172
What this trial is testing

A Phase II Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Exosomes Overexpressing CD24 to Prevent Clinical Deterioration in Patients With Moderate or Severe COVID-19 Infection

Who this might be right for
COVID-19 Disease
Eli Sprecher, MD 155
Testing effectiveness (Phase 2)Study completedNCT01530698
What this trial is testing

Single-step Antigen Loading and TLR Activation of Dendritic Cells in Melanoma Patients

Who this might be right for
Melanoma
Radboud University Medical Center 28
Testing effectiveness (Phase 2)Study completedNCT01204684
What this trial is testing

Dendritic Cell Vaccine for Patients With Brain Tumors

Who this might be right for
GliomaAnaplastic AstrocytomaAnaplastic Astro-oligodendroglioma+1 more
Jonsson Comprehensive Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT00960752
What this trial is testing

Tumor and Vaccine Site With a Toll Like Receptor (TLR) Agonist

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 47
Not applicableStudy completedNCT04791397
What this trial is testing

Evaluation of the Effect of IHHT on Vascular Stiffness and Elasticity of the Liver Tissue in Patients With MS.

Who this might be right for
Vascular StiffnessLiver FibrosesMetabolic Syndrome+2 more
I.M. Sechenov First Moscow State Medical University 62
Not applicableStudy completedNCT02897167
What this trial is testing

Study of the Activation of Proinflammatory Pathways of Toll-like Receptors in Schizophrenia Patients

Who this might be right for
SchizophreniaMental DisordersPsychotic Disorders
Fundación Marques de Valdecilla 150
Not applicableWithdrawnNCT03943407
What this trial is testing

Characterization of the Toll-like Receptor 7-agonist Imiquimod 3.75% As a New Surrogate Model of Itch

Who this might be right for
Itch
Aalborg University
Testing effectiveness (Phase 2)Study completedNCT00940004
What this trial is testing

Toll-like Receptor (TLR) Ligand Matured Dendritic Cell Vaccination in Melanoma Patients

Who this might be right for
Melanoma
Radboud University Medical Center 20
Early research (Phase 1)Study completedNCT01808469
What this trial is testing

First in Human Study of an Anti-Toll-like Receptor 4 (TLR4) Monoclonal Antibody (NI-0101) in Adult Healthy Volunteers

Who this might be right for
Healthy Volunteers
Light Chain Bioscience - Novimmune SA 80
Not applicableLooking for participantsNCT06755372
What this trial is testing

The Role of Toll-like Receptor-4 in Periodontitis Patients With End-stage Renal Disease in a Sample of Egyptian Population

Who this might be right for
PeriodontitisEnd-stage Renal Disease
Ain Shams University 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05540327
What this trial is testing

The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)

Who this might be right for
Systemic Lupus Erythematosus
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 379
Next Page